
Post

Komoh
Moderna Q3 Outlook: Moderna (MRNA) is set to report its Q3 results before the US market open on Nov 6, following a net loss of approximately $800M in Q2.
Market Sentiment: Sentiment on the prediction market "Will Moderna (MRNA) beat quarterly earnings?" leans heavily optimistic, with 94% voting "Yes" against 6% for "No" on a volume of 2.61M.
#ModernaQ3VaccineSales

Disclaimer: OKX Orbit content is provided for informational purposes only. Learn more
Replies
No comments yet. Be the first to reply!
Trending crypto
BTC/USDTBitcoin
$61,951.4-0.02%
ETH/USDTEthereum
$1,754.38-0.02%
SOL/USDTSolana
$73.07-0.01%
Today’s market buzz
1#AnthropicNasdaqDebut
Hot

2#HawkishOctFOMCMinutes
3#GTA6LaunchTTWOOutlook

